Heparin Concept

subject area of

• 10 Anticoagulant therapy in venous thromboembolism  Academic Article
• 15 Side-effects of antithrombotic therapy  Academic Article
• 4 Clinical potential of low molecular weight heparins  Academic Article
• 4Ts scoring with hemofiltration or hemodialysis clotting  Academic Article
• ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia  Academic Article
• A 14-year study of heparin-induced thrombocytopenia  Academic Article
• A Comparative Randomized Trial of Low-Dose Versus High-Dose Streptokinase in Deep Vein Thrombosis of the Thigh  Academic Article
• A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis  Academic Article
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease  Academic Article
• A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation  Academic Article
• A Computer Generated Induction System for Hospitalized Patients Starting on Oral Anticoagulant Therapy  Academic Article
• A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats  Academic Article
• A Histomorphometric Evaluation of Heparin-Induced Bone Loss After Discontinuation of Heparin Treatment in Rats  Academic Article
• A Low Molecular Weight Heparin Alters the Fetal Coagulation System in the Pregnant Sheep  Academic Article
• A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke  Academic Article
• A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism  Academic Article
• A Meta-analysis of the Studies of Dihydroergotamine plus Heparin in the Prophylaxis of Deep Vein Thrombosis  Academic Article
• A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial  Academic Article
• A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time  Academic Article
• A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery  Academic Article
• A Systematic Review of Heparin to Treat Burn Injury  Academic Article
• A comparative study of platelet factor 4‐enhanced platelet activation assays for the diagnosis of heparin‐induced thrombocytopenia  Academic Article
• A comparison of continuous infusion and intermittent flushing methods in peripheral intravenous catheters in neonates.  Academic Article
• A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation  Academic Article
• A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo  Academic Article
• A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis  Academic Article
• A diagnostic test for heparin-induced thrombocytopenia  Academic Article
• A diagnostic test for heparin‐induced thrombocytopenia: detection of platelet microparticles using flow cytometry  Academic Article
• A novel antithrombin-heparin covalent complex  Academic Article
• A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia  Academic Article
• A practical approach to evaluating postoperative thrombocytopenia  Academic Article
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Academic Article
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Academic Article
• A prospective study measuring the development of antibodies against platelet factor 4–heparin in healthy males after exposure to heparins  Academic Article
• A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions  Academic Article
• A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin  Academic Article
• A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction  Academic Article
• A standard heparin nomogram for the management of heparin therapy  Academic Article
• A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism  Academic Article
• A thrombin receptor function for platelet glycoprotein Ib–IX unmasked by cleavage of glycoprotein V  Academic Article
• A unified method for regional anticoagulation of blood.  Academic Article
• ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies  Academic Article
• ATENOLOL, HEPARIN AND THE INTERMEDIATE CORONARY SYNDROME  Academic Article
• AUSTRALIAN MULTICENTRE TRIAL OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION  Academic Article
• AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose-ranging study  Academic Article
• Activated Clotting Time and Outcomes During Percutaneous Coronary Intervention for Non–ST-Segment–Elevation Myocardial Infarction  Academic Article
• Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors  Academic Article
• Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial Infarction  Academic Article
• Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium  Academic Article
• Activation of blood coagulation by plaque rupture: Mechanisms and prevention  Academic Article
• Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and d-Phe-Pro-Arg-Ch2Cl  Academic Article
• Activation of factor X and prothrombin in antithrombin-III depleted plasma: The effects of heparin  Academic Article
• Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia  Academic Article
• Acute Thrombocytopenia and Thrombosis.  Academic Article
• Acute coronary syndromes: a focus on thrombin.  Academic Article
• Acute intraoperative HIT during heart surgery: Why so rare?  Academic Article
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation  Academic Article
• Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness  Academic Article
• Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia  Academic Article
• Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis  Academic Article
• Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis  Academic Article
• Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis  Academic Article
• Adverse outcomes associated with managing suspected heparin induced thrombocytopenia in the critically ill  Academic Article
• Age-related differences in heparin response  Academic Article
• Agents for the Treatment of Heparin-Induced Thrombocytopenia  Academic Article
• Airways Disease Presenting as Restrictive Impairment: Response  Academic Article
• Alpha-2-Macroglobulin Is an Important Progressive Inhibitor of Thrombin in Neonatal and Infant Plasma  Academic Article
• Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children  Academic Article
• Altered inactivation of trinitrophenylated thrombin by antithrombin iii in the presence of heparin  Academic Article
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia  Academic Article
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy  Academic Article
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients  Academic Article
• An Approach to Assigning In Vitro Potency to Unfractionated and Low Molecular Weight Heparins Based on the Inhibition of Prothrombin Activation and Catalysis of Thrombin Inhibition  Academic Article
• An Economic Evaluation of rt-PA Locking Solution in Dialysis Catheters  Academic Article
• An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients  Academic Article
• An Instrument-based Immunoassay with an Appropriate Normal Range: Minimizing HIT Overdiagnosis  Academic Article
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction  Academic Article
• An Overview of the Heparin-Induced Thrombocytopenia Syndrome  Academic Article
• An algorithm for resolving ‘indeterminate’ test results in the platelet serotonin release assay for investigation of heparin‐induced thrombocytopenia  Academic Article
• An international external quality assessment for laboratory diagnosis of heparin‐induced thrombocytopenia  Academic Article
• An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) Investigators.  Academic Article
• An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial  Academic Article
• Analysis of Inhibition Rate Enhancement by Covalent Linkage of Antithrombin to Heparin as a Potential Predictor of Reaction Mechanism  Academic Article
• Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients  Academic Article
• Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study  Academic Article
• Analysis of proteins adsorbed to glass from human plasma using immunoblotting methods  Academic Article
• Analytical assessment of ortho clinical diagnostics high-sensitivity cardiac troponin I assay  Academic Article
• Ancrod (Arvin®) as an Alternative to Heparin Anticoagulation for Cardiopulmonary Bypass  Academic Article
• Antemortem Heparin in Organ Donation After Circulatory Death Determination: A Systematic Review of the Literature  Academic Article
• Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial  Academic Article
• Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia  Academic Article
• Anticoagulant Actions of Tissue Factor Pathway Inhibitor on Tissue-Factor-Dependent Plasma Coagulation  Academic Article
• Anticoagulant Effects of Heparin in Neonatal Plasma'  Academic Article
• Anticoagulant Mechanisms of Orgaran (Org 10172) and Its Fraction with High Affinity to Antithrombin III (Org 10849)  Academic Article
• Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls  Academic Article
• Anticoagulant response after dalteparin overdose  Academic Article
• Anticoagulant therapy after acute myocardial infarction  Academic Article
• Anticoagulants During Pregnancy  Academic Article
• Anticoagulants and Their Reversal  Academic Article
• Anticoagulants in Venous Thromboembolism  Academic Article
• Anticoagulants in pregnancy: A review of indications and complications  Academic Article
• Anticoagulation Therapy in Children  Academic Article
• Anticoagulation Therapy in Pediatric Patients With Sinovenous Thrombosis  Academic Article
• Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• Anticoagulation for cardiopulmonary bypass: Is a replacement for heparin on the horizon?  Academic Article
• Anticoagulation for patients with cancer and central venous catheters  Academic Article
• Anticoagulation for people with cancer and central venous catheters  Academic Article
• Anticoagulation for people with cancer and central venous catheters  Academic Article
• Anticoagulation for people with cancer and central venous catheters  Academic Article
• Anticoagulation for perioperative thromboprophylaxis in people with cancer  Academic Article
• Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis  Academic Article
• Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters  Academic Article
• Anticoagulation in venous Thrombosis  Academic Article
• Anticoagulation of Pregnant Women With Mechanical Heart Valves  Academic Article
• Anticoagulation therapy in neonates, children and adolescents  Academic Article
• Antiphospholipid Syndrome During Septic Shock: Hyper- or Hypocoagulability?: A Case Report  Academic Article
• Antiphospholipid and anti‐PF4 antibodies: an association affecting anti‐PF4/heparin assay analysis  Academic Article
• Antiphospholipid antibody syndrome  Academic Article
• Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations  Academic Article
• Antithrombin-Heparin Covalent Complex  Academic Article
• Antithrombin-III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity  Academic Article
• Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity  Academic Article
• Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model  Academic Article
• Antithrombins: Their Potential as Antithrombotic Agents  Academic Article
• Antithrombotic Agents in Coronary Artery Disease  Academic Article
• Antithrombotic Drugs  Academic Article
• Antithrombotic Properties of Heparin in a Neonatal Piglet Model of Thrombin-Induced Thrombosis  Academic Article
• Antithrombotic Therapy During Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• Antithrombotic Therapy in Children*  Academic Article
• Antithrombotic Therapy in Neonates and Children  Academic Article
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Academic Article
• Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents  Academic Article
• Antithrombotic therapy in children with venous thromboembolism  Academic Article
• Antithrombotic therapy in deep vein thrombosis and pulmonary embolism.  Academic Article
• Anti‐PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis  Academic Article
• Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein  Academic Article
• Anti–protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis  Academic Article
• Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia  Academic Article
• Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.  Academic Article
• Are heparins anti-neoplastic agents?  Academic Article
• Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia  Academic Article
• Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia  Academic Article
• Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia  Academic Article
• Argatroban as a Heparin Substitute in Cases of Heparin-Induced Thrombocytopenia  Academic Article
• Article Commentary: Heparin and the Peritoneal Membrane  Academic Article
• Aspirin and heparin to improve live birth rate in IVF for unexplained implantation failure?  Academic Article
• Assessing matrix, interferences and comparability between the Abbott Diagnostics and the Beckman Coulter high-sensitivity cardiac troponin I assays  Academic Article
• Assessment of antithrombotic drugs ex vivo and in vivo.  Academic Article
• Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery  Academic Article
• Asymmetric distribution of sites with high affinity for antithrombin III in rat skin heparin proteoglycans.  Academic Article
• Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma  Conference Paper
• Autoimmune heparin‐induced thrombocytopenia  Academic Article
• Autoimmune heparin‐induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin  Academic Article
• B cells, PF4/heparin complexes, and complement  Academic Article
• Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial  Academic Article
• Benefit of Heparin in Central Venous and Pulmonary Artery Catheters  Academic Article
• Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials  Academic Article
• Beta-Thromboglobulin Radioimmunoassay. A Laboratory Characterization and Evaluation  Academic Article
• Beyond Unfractionated Heparin and Warfarin  Academic Article
• Beyond heparin and warfarin: the new generation of anticoagulants  Academic Article
• Binding of Heparin to Metals  Academic Article
• Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin  Academic Article
• Biodistribution of covalent antithrombin-heparin complexes  Academic Article
• Biologic rationale for the therapeutic role of specific antithrombins  Academic Article
• Bivalent Binding to γA/γ′-Fibrin Engages Both Exosites of Thrombin and Protects It from Inhibition by the Antithrombin-Heparin Complex  Academic Article
• Bivalirudin  Academic Article
• Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.  Academic Article
• Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Initially Treated with Fondaparinux: Results from an International, Multicenter, Randomized Pilot Study (  Academic Article
• Bleeding associated with antithrombotic therapy.  Academic Article
• Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents  Academic Article
• Blood-compatible biomaterials by surface coating with a novel antithrombin–heparin covalent complex  Academic Article
• By Increasing the Affinity of Heparin for Fibrin, Zn²⁺ Promotes the Formation of a Ternary Heparin–Thrombin–Fibrin Complex That Protects Thrombin from Inhibition by Antithrombin  Academic Article
• COVID-19 versus HIT hypercoagulability  Academic Article
• Calcium protects pituitary basic fibroblast growth factors from limited proteolysis by co-purifying proteases  Academic Article
• Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?  Academic Article
• Canadian Consensus Conference on Coronary Thrombolysis--1994 update.  Academic Article
• Carbon monoxide-releasing molecule CORM-3 suppresses vascular endothelial cell SOD-1/SOD-2 activity while up-regulating the cell surface levels of SOD-3 in a heparin-dependent manner  Academic Article
• Catalysis of Thrombin Inhibition Provides an Index for Estimating the Antithrombotic Potential of Glycosaminoglycans in Rabbits  Academic Article
• Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia  Academic Article
• Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia  Academic Article
• Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial  Academic Article
• Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty  Academic Article
• Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies  Academic Article
• Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity  Academic Article
• Characterization of Heparin Aerosols Generated in Jet and Ultrasonic Nebulizers  Academic Article
• Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin‐induced thrombocytopenia  Academic Article
• Chemical–Physical Characterization of Polyurethane Catheters Modified with a Novel Antithrombin-Heparin Covalent Complex  Academic Article
• Chromatography of heparin on Sepharose–lysine: molecular size fractionation and its relevance to thrombin and antithrombin III binding  Academic Article
• Chronic performance of polyurethane catheters covalently coated with ATH complex: A rabbit jugular vein model  Academic Article
• Circulating heparin‐like anticoagulants: Case report and review of literature  Academic Article
• Clinical Experience with Anticoagulant Therapy During Pregnancy  Academic Article
• Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy  Academic Article
• Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective  Academic Article
• Clinical Use of Low Molecular Weight Heparins and Heparinoids  Academic Article
• Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin‐induced thrombocytopenia  Academic Article
• Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials  Academic Article
• Clinical factors influencing the sensitivity to warfarin when restarted after surgery  Academic Article
• Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis  Academic Article
• Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry  Academic Article
• Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia  Academic Article
• Clinical potential of antithrombotic drugs in coronary syndromes  Academic Article
• Clinical presentation of heparin-induced thrombocytopenia.  Academic Article
• Clinical sample investigation (CSI) hematology: pinpointing the precise onset of heparin‐induced thrombocytopenia (HIT)  Academic Article
• Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia.  Academic Article
• Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT Antibodies  Academic Article
• Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.  Academic Article
• Coagulation Assays  Academic Article
• Coagulation Disorders and Blood Product Use in Patients Undergoing Thoracoabdominal Aortic Aneurysm Repair  Academic Article
• Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass  Academic Article
• Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study  Academic Article
• Combination of two complementary automated rapid assays for diagnosis of heparin‐induced thrombocytopenia (HIT)  Academic Article
• Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles  Academic Article
• Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist  Academic Article
• Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay  Academic Article
• Comment: Treatment of Heparin-Induced Thrombocytopenia  Academic Article
• Comparative behavior of thrombin and an inactive derivative, FPR-thrombin, toward the rabbit vascular endothelium. Heparin liberates FPR-thrombin from the endothelium in vivo.  Academic Article
• Comparative effects of heparin and LMW heparin on hemostasis  Conference Paper
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conference Paper
• Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome  Academic Article
• Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism  Academic Article
• Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction  Academic Article
• Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease  Academic Article
• Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia  Academic Article
• Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)  Academic Article
• Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial  Academic Article
• Comparison of recombinant and plasma-derived antithrombin biodistribution in a rabbit model  Academic Article
• Comparison of the Effects of Heparin and Hirudin on Thrombin Binding to the Normal and the De-Endothelialized Rabbit Aorta In Vitro  Academic Article
• Comparison of the Effects of Two Doses of Recombinant Hirudin Compared With Heparin in Patients With Acute Myocardial Ischemia Without ST Elevation  Academic Article
• Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins  Academic Article
• Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models  Academic Article
• Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism.  Academic Article
• Comparison of the haemorrhagic effects of porcine and bovine heparin in rabbits  Academic Article
• Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction  Academic Article
• Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.  Academic Article
• Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis.  Academic Article
• Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients  Academic Article
• Complement and the antiphospholipid syndrome  Academic Article
• Complex formation of platelet thrombospondin with histidine-rich glycoprotein.  Academic Article
• Confirmatory procedure and other maneuvers to assess pathogenicity of platelet factor 4 (PF4)-dependent antibodies – distinguishing "signal" from "noise"  Academic Article
• Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes  Academic Article
• Contaminated Heparin  Academic Article
• Continuing Challenges of Sepsis Research  Academic Article
• Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis  Academic Article
• Contribution of Red Blood Cells to the Saturable Mechanism of Heparin Clearance  Academic Article
• Cost Effectiveness of Continued-Warfarin Versus Heparin-Bridging Therapy During Pacemaker and Defibrillator Surgery  Academic Article
• Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients  Academic Article
• Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients.  Academic Article
• Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis  Academic Article
• Covalent Antithrombin-Heparin Complexes with High Anticoagulant Activity  Academic Article
• Covalent Heparin Cofactor II-Heparin and Heparin Cofactor II-Dermatan Sulfate Complexes  Academic Article
• Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va  Academic Article
• Covalent antithrombin–heparin complexes  Academic Article
• Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets  Academic Article
• Current agents for the treatment of patients with heparin-induced thrombocytopenia  Academic Article
• D-Dimer and Thrombin-Antithrombin III Complexes in Patients with Clinically Suspected Pulmonary Embolism  Academic Article
• DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE  Academic Article
• Dalteparin and Heparin-Induced Thrombocytopenia  Academic Article
• Dalteparin versus Unfractionated Heparin in Critically Ill Patients  Academic Article
• Dealing with Drug-Induced Thrombocytopenia  Academic Article
• Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential  Academic Article
• Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass  Academic Article
• Deep Vein Thrombosis and Its Prevention in Critically Ill Adults  Academic Article
• Deep Vein Thrombosis: Recovery or Recurrence?  Academic Article
• Deep venous thrombosis as a cause of stump swelling in two lower extremity amputee patients.  Academic Article
• Deep venous thrombosis in the medically ill.  Academic Article
• Defining the heparin-binding domain of antithrombin  Academic Article
• Delayed-Onset Heparin-Induced Thrombocytopenia and Cerebral Thrombosis after a Single Administration of Unfractionated Heparin  Academic Article
• Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis  Academic Article
• Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: A consequence of heparin “flushes”  Academic Article
• Demand on-demand testing for the diagnosis of heparin-induced thrombocytopenia  Academic Article
• Dermatan sulphate in heparin-induced thrombocytopenia  Academic Article
• Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy  Academic Article
• Design of the rivaroxaban for heparin-induced thrombocytopenia study  Academic Article
• Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial  Academic Article
• Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.  Academic Article
• Development of a high-yield expression and purification system for platelet factor 4  Academic Article
• Device Surgery without Interruption of Anticoagulation  Academic Article
• Device surgery without interruption of anticoagulation.  Academic Article
• Diagnosis of Heparin-induced Thrombocytopenia:Still a Journey, Not Yet a Destination  Academic Article
• Diagnosis of thrombosis. Evaluation of 125I-fibrinogen scanning and blood tests.  Academic Article
• Diagnostic accuracy of IgG‐specific versus polyspecific enzyme‐linked immunoassays in heparin‐induced thrombocytopenia: a systematic review and meta‐analysis  Academic Article
• Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis  Academic Article
• Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review  Academic Article
• Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin  Conference Paper
• Direct thrombin inhibitors in acute coronary syndromes  Academic Article
• Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention  Academic Article
• Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data  Academic Article
• Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction  Academic Article
• Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia  Academic Article
• Dosing Frequency of Unfractionated Heparin Thromboprophylaxis  Academic Article
• Drug-Induced Immune-Mediated Thrombocytopenia — From Purpura to Thrombosis  Academic Article
• Drug-Induced Platelet Destruction  Academic Article
• EFFECT OF SERA ON THROMBIN ACTIVATION RATE CONSTANTS: A ONE-STAGE ASSAY OF THE EXTRINSIC SYSTEM  Academic Article
• EVALUATION OF SUBCUTANEOUS CALCIUM HEPARIN THERAPY IN THE TREATMENT OF THROMBO‐EMBOLIC DISEASE  Academic Article
• EXPERIMENTAL PRODUCTION OF MICROANGIOPATHIC HÆMOLYTIC ANÆMIA IN VIVO  Academic Article
• Early rate of resolution of major pulmonary embolism. A study of angiographic and haemodynamic changes occurring in the first 24 to 48 hours.  Academic Article
• Early‐onset and persisting thrombocytopenia in post‐cardiac surgery patients is rarely due to heparin‐induced thrombocytopenia, even when antibody tests are positive  Academic Article
• Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction].  Academic Article
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Academic Article
• Effect of Heparin Loading During Congenital Heart Operation on Thrombin Generation and Blood Loss  Academic Article
• Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate  Academic Article
• Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin  Academic Article
• Effect of a novel covalent antithrombin-heparin complex on thrombin generation on fetal distal lung epithelium  Academic Article
• Effect of anti‐platelet factor‐4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery  Academic Article
• Effect of covalent antithrombin-heparin complex on developmental mechanisms in the lung  Academic Article
• Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor  Academic Article
• Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin  Academic Article
• Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.  Academic Article
• Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro  Academic Article
• Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography  Academic Article
• Effectiveness of Anticoagulants  Academic Article
• Effects of Dermatan Sulfate and Heparin on Inhibition of Thrombus Growth in Vivo  Academic Article
• Effects of Sulfated Polysaccharides on Inhibition of Thrombus Formation initiated by Different Stimuli  Academic Article
• Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in Rabbits  Academic Article
• Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment  Academic Article
• Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III  Academic Article
• Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth  Academic Article
• Effects of high fat provision on muscle PDH activation and malonyl-CoA content in moderate exercise  Academic Article
• Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina  Academic Article
• Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial  Academic Article
• Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty  Academic Article
• Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention  Academic Article
• Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients  Academic Article
• Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19  Academic Article
• Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement  Academic Article
• Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment  Academic Article
• Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis  Academic Article
• End of the road for heparin thromboprophylaxis  Academic Article
• Enhanced Cellular Uptake of Remnant High-Density Lipoprotein Particles  Academic Article
• Enhanced binding of fibrinogen by the subendothelium after treatment of the rabbit aorta with thrombin.  Academic Article
• Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction  Academic Article
• Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction  Academic Article
• Erythrocyte insulin receptors remain intact through three days of storage  Academic Article
• Establishing a Therapeutic Range for Heparin Therapy  Academic Article
• Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis  Academic Article
• Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings  Academic Article
• Evidence and clinical judgment: Treatment of cerebral vein thrombosis  Academic Article
• Evidence for a saturable mechanism of disappearance of standard heparin in rabbits  Academic Article
• Evidence that Rabbit ¹²⁵I-Antithrombin III Binds to Proteoheparan Sulphate at the Subendothelium of the Rabbit Aorta in vitro  Academic Article
• Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis  Academic Article
• Evidence-Based Management of Anticoagulant Therapy  Academic Article
• Evidence-based treatment of the antiphospholipid syndrome  Academic Article
• Ex-Vivo and In-Vitro Evidence that Low Molecular Weight Heparins Exhibit Less Binding to Plasma Proteins than Unfractionated Heparin  Academic Article
• Executive Summary  Academic Article
• Exosites 1 and 2 Are Essential for Protection of Fibrin-bound Thrombin from Heparin-catalyzed Inhibition by Antithrombin and Heparin Cofactor II  Academic Article
• Expression in a cell-free system of normal and variant forms of human antithrombin III. Ability to bind heparin and react with alpha-thrombin  Academic Article
• Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study  Academic Article
• Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?  Academic Article
• Factor V Leiden and Thrombotic Complications in Heparin-induced Thrombocytopenia  Academic Article
• Factors responsible for ADP-induced release reaction of human platelets  Article
• Factors responsible for target site selection in Tn10 transposition: a role for the DDE motif in target DNA capture  Academic Article
• Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists  Academic Article
• Fatal heparin‐induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of ‘spontaneous’ HIT?  Academic Article
• Fate of Thrombin and Thrombin-Antithrombin-III Complex Adsorbed to a Heparinized Biomaterial: Analysis of the Enzyme-Inhibitor Complexes Displaced by Plasma  Academic Article
• FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia  Academic Article
• Feasibility of Using Recombinant Factor VIIa in Continuous Infusion  Academic Article
• Fetal and neonatal outcome of exposure to anticoagulants during pregnancy  Academic Article
• Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.  Academic Article
• Fibrinogen Catabolism in Microangiopathic Haemolytic Anaemia  Academic Article
• Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT  Academic Article
• Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban  Academic Article
• Fondaparinux for Treatment of Heparin-Induced Thrombocytopenia  Academic Article
• Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study  Academic Article
• Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke  Academic Article
• Fondaparinux treatment of acute heparin‐induced thrombocytopenia confirmed by the serotonin‐release assay: a 30‐month, 16‐patient case series  Academic Article
• Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin  Academic Article
• Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux  Academic Article
• Fondaparinux: does it cause HIT? can it treat HIT?  Academic Article
• Formation of anti–platelet factor 4/heparin antibodies after cardiac surgery: Influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen status  Academic Article
• Frequency of Heparin-Induced Thrombocytopenia in Critical Care Patients  Academic Article
• From unfractionated heparins to low molecular weight heparins.  Academic Article
• Further complexities in diagnosing acquired thrombocytopenia: unexpected parallels between antibody-mediated delayed thrombocytopenia with abciximab and heparin induced thrombocytopenia  Academic Article
• Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia  Academic Article
• Generic Bioaffinity Silicone Surfaces  Academic Article
• Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia  Academic Article
• Glycosaminoglycans Bind Factor Xa in a Ca²⁺-Dependent Fashion and Modulate Its Catalytic Activity  Academic Article
• Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.  Academic Article
• Guide to Anticoagulant Therapy: Heparin  Academic Article
• Guide to Anticoagulant Therapy: Heparin  Academic Article
• Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.  Academic Article
• HEPARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE: ADMINISTRATION, CONTROL AND RESULTS  Academic Article
• HEPARIN TREATMENT OF HAEMOLYSIS AND THROMBOCYTOPENIA IN PRE-ECLAMPSIA. Report of a Case and a Review of the Literature  Academic Article
• HIT paradigms and paradoxes  Academic Article
• HIT: Lessons Learned  Conference Paper
• HITlights: A career perspective on heparin-induced thrombocytopenia  Academic Article
• Hemodialysis-Associated Acute Systemic Reactions and Heparin-Induced Thrombocytopenia  Academic Article
• Hemorrhagic Complications of Anticoagulant Therapy  Academic Article
• Hemorrhagic Complications of Anticoagulant Treatment  Academic Article
• Hemorrhagic Complications of Anticoagulant Treatment  Academic Article
• Hemorrhagic Complications of Anticoagulant Treatment  Academic Article
• Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated?  Academic Article
• Hemorrhagic complications of anticoagulant treatment.  Academic Article
• Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect  Academic Article
• Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.  Academic Article
• Heparin  Academic Article
• Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance  Academic Article
• Heparin Brand Is Associated With Postsurgical Outcomes in Children Undergoing Cardiac Surgery  Academic Article
• Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate  Academic Article
• Heparin Dependent Coiled‐Coil Formation  Academic Article
• Heparin Effect on Bone Density  Academic Article
• Heparin Improves Gas Exchange during Experimental Acute Lung Injury in Newborn Piglets  Academic Article
• Heparin Inhibits Melatonin Binding and Signal Transduction in Chick Brain  Academic Article
• Heparin Synergistically Enhances Interleukin-11 Signaling through Up-regulation of the MAPK Pathway  Academic Article
• Heparin Therapy in Venous Thromboembolism  Academic Article
• Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss  Academic Article
• Heparin Treatment of Haemolytic Anæmia and Thrombocytopenia in Pre-Eclampsia  Academic Article
• Heparin and Angiogenesis  Academic Article
• Heparin and Graduated Compression Stockings in Patients  Academic Article
• Heparin and Low Molecular Weight Heparins Inhibit Prothrombinase Formation but not its Activity in Plasma  Academic Article
• Heparin and Low-Molecular-Weight Heparin  Academic Article
• Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety  Academic Article
• Heparin and Platelets  Academic Article
• Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases  Academic Article
• Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.  Academic Article
• Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarction  Academic Article
• Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.  Academic Article
• Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoprotein  Academic Article
• Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far?  Academic Article
• Heparin clearance and ex vivo recovery in newborn piglets and adult pigs  Academic Article
• Heparin compromises streptokinase-induced arterial patency in rabbits  Academic Article
• Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells  Academic Article
• Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis  Academic Article
• Heparin for Mural Thrombosis in Anterior Myocardial Infarction  Academic Article
• Heparin for Proximal-Vein Thrombosis  Academic Article
• Heparin for prolonging peripheral intravenous catheter use in neonates  Academic Article
• Heparin in the Treatment of Thromboembolic Stroke  Academic Article
• Heparin induced bleeding.  Academic Article
• Heparin induced thrombocytopenia  Academic Article
• Heparin inhibits thrombin binding to rabbit thoracic aorta endothelium.  Academic Article
• Heparin kinetics in venous thrombosis and pulmonary embolism.  Academic Article
• Heparin or nonheparin anticoagulants for VITT  Academic Article
• Heparin resistance in acute coronary syndromes  Academic Article
• Heparin sensitivity and resistance in the neonate: An explanation  Academic Article
• Heparin therapy during pregnancy. Risks to the fetus and mother  Academic Article
• Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns  Academic Article
• Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma  Academic Article
• Heparin, DDAVP and the Bleeding Time  Academic Article
• Heparin-Associated Thrombocytopenia  Academic Article
• Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia Associated with Fondaparinux  Academic Article
• Heparin-Induced Thrombocytopenia Presenting as Bilateral Adrenal Hemorrhages  Academic Article
• Heparin-Induced Thrombocytopenia and Vascular Surgery  Academic Article
• Heparin-Induced Thrombocytopenia in Critically Ill Patients  Academic Article
• Heparin-Induced Thrombocytopenia in Critically Ill Patients  Academic Article
• Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin  Academic Article
• Heparin-Induced Thrombocytopenia in Patients with Ventricular Assist Devices: Are New Prevention Strategies Required?  Academic Article
• Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and Testing  Academic Article
• Heparin-Induced Thrombocytopenia in the ICU  Academic Article
• Heparin-Induced Thrombocytopenia: A Clinicopathologic Syndrome  Academic Article
• Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective  Academic Article
• Heparin-Induced Thrombocytopenia: An Iceberg Rising  Academic Article
• Heparin-Induced Thrombocytopenia: Real-World Issues  Academic Article
• Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention  Academic Article
• Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia  Academic Article
• Heparin-binding serum protein(s) is required for the protection of sialyltransferase released during the incubation of rat jejunal slices  Academic Article
• Heparin-induced Thrombocytopenia  Academic Article
• Heparin-induced Thrombocytopenia: Towards Consensus  Academic Article
• Heparin-induced Thrombocytopenia: Yet Another Treatment Paradox?  Academic Article
• Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes  Academic Article
• Heparin-induced skin necrosis  Academic Article
• Heparin-induced thrombocytopenia  Academic Article
• Heparin-induced thrombocytopenia  Academic Article
• Heparin-induced thrombocytopenia and cardiac surgery  Academic Article
• Heparin-induced thrombocytopenia and cardiac surgery  Academic Article
• Heparin-induced thrombocytopenia and its treatment.  Conference Paper
• Heparin-induced thrombocytopenia and the anesthesiologist.  Academic Article
• Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies  Academic Article
• Heparin-induced thrombocytopenia in 2017 and beyond  Academic Article
• Heparin-induced thrombocytopenia in intensive care patients  Academic Article
• Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass  Academic Article
• Heparin-induced thrombocytopenia in renal failure.  Academic Article
• Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^  Academic Article
• Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial  Academic Article
• Heparin-induced thrombocytopenia.  Academic Article
• Heparin-induced thrombocytopenia.  Conference Paper
• Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings  Academic Article
• Heparin-induced thrombocytopenia: What the serologists have taught us  Academic Article
• Heparin-induced thrombocytopenia: a historical perspective  Academic Article
• Heparin-induced thrombocytopenia: an overview  Academic Article
• Heparin-induced thrombocytopenia: laboratory studies  Academic Article
• Heparin-induced thrombocytopenia: pathogenesis and management  Academic Article
• Heparin-induced thrombocytopenia: pathogenesis and management  Academic Article
• Heparin-induced thrombocytopenia: patient profiles and clinical manifestations.  Academic Article
• Heparin-induced thrombosis without thrombocytopenia  Academic Article
• Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2)  Academic Article
• Heparin-modified dendrimer crosslinked collagen matrices for the delivery of heparin-binding epidermal growth factor  Academic Article
• Heparin/Heparan Sulfate (HP/HS) Interacting Protein (HIP) Supports Cell Attachment and Selective, High Affinity Binding of HP/HS  Academic Article
• Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.  Academic Article
• Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.  Academic Article
• Heparin‐induced skin lesions  Academic Article
• Heparin‐induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery ‘spontaneous’ HIT  Academic Article
• Heparin‐induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes  Academic Article
• Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes  Academic Article
• Heparin‐induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests  Academic Article
• Heparin‐induced thrombocytopenia‐associated thrombosis: from arterial to venous to venous limb gangrene  Academic Article
• High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT  Academic Article
• High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review  Academic Article
• High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome  Academic Article
• Hirudin causes more bleeding than heparin in a rabbit ear bleeding model  Academic Article
• Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo  Academic Article
• How I Diagnose and Manage HIT  Academic Article
• How I treat patients with a history of heparin-induced thrombocytopenia  Academic Article
• How can we reduce disagreement among guidelines for venous thromboembolism prevention?  Academic Article
• How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice  Academic Article
• How to use unfractionated heparin to treat neonatal thrombosis in clinical practice  Academic Article
• Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.  Academic Article
• Hypercoagulable States  Academic Article
• Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients  Academic Article
• Hypersulfated Low Molecular Weight Heparin with Reduced Affinity for Antithrombin Acts as an Anticoagulant by Inhibiting Intrinsic Tenase and Prothrombinase  Academic Article
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction  Academic Article
• ISTH guidelines for antithrombotic treatment in COVID‐19  Academic Article
• Identification of apolipoprotein A-I as a major adsorbate on biomaterial surfaces after blood or plasma contact  Academic Article
• Identification of proteins adsorbed to hemodialyser membranes from heparinized plasma  Academic Article
• Idiosyncratic Drug-Induced Thrombocytopenia1  Academic Article
• Idiosyncratic Drug-Induced Thrombocytopenia1  Academic Article
• Immobilization of an antithrombin–heparin complex on gold: Anticoagulant properties and platelet interactions  Academic Article
• Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer  Academic Article
• Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin  Academic Article
• Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies  Academic Article
• Immunoassays are not created equal  Academic Article
• Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4  Academic Article
• Immunospecific analysis of in vitro and ex vivo surface-immobilized protein complex  Academic Article
• Impact of Switching Sample Types for High-Sensitivity Cardiac Troponin I Assays in the 0/1 Hour Algorithms  Academic Article
• Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction  Academic Article
• Impact of the patient population on the risk for heparin-induced thrombocytopenia  Academic Article
• Importance of the spatial display of charged residues in heparin–peptide interactions  Academic Article
• Improved Bovine ICSI Outcomes by Sperm Selected after Combined Heparin-Glutathione Treatment  Academic Article
• Improving Clinical Interpretation of the Anti-Platelet Factor 4/Heparin Enzyme-Linked Immunosorbent Assay for the Diagnosis of Heparin-Induced Thrombocytopenia Through the Use of Receiver Operating Characteristic Analysis, Stratum-Specific Likelihood Ratios, and Bayes Theorem  Academic Article
• In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke.  Academic Article
• In the Presence of Phospholipids, Glycosaminoglycans Potentiate Factor Xa-Mediated Protein C Activation by Modulating Factor Xa Activity  Academic Article
• In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation  Academic Article
• In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding  Academic Article
• In vivo activity of a new heparinoid.  Academic Article
• In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex  Academic Article
• Inactivation of thrombin by antithrombin III on a heparinized biomaterial  Academic Article
• Inadequacy of intravenous heparin therapy in the initial management of venous thromboembolism  Academic Article
• Incidence and clinical relevance of anti–platelet factor 4/heparin antibodies before cardiac surgery  Academic Article
• Increased heparin clearance in experimental pulmonary embolism.  Academic Article
• Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex  Academic Article
• Induction of the Acute-Phase Reaction Increases Heparin-Binding Proteins in Plasma  Academic Article
• Inhibition of Fibrin-Bound Thrombin by a Covalent Antithrombin-Heparin Complex  Academic Article
• Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma  Academic Article
• Inhibition of osteolytic bone metastasis by unfractionated heparin  Academic Article
• Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin–heparin complex  Academic Article
• Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes.  Academic Article
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction  Academic Article
• Inhibition of the prothrombinase complex on red blood cells by heparin and covalent antithrombin-heparin complex  Academic Article
• Initial Experience With Viabahn VBX as the Bridging Stent Graft for Branched and Fenestrated Endovascular Aneurysm Repair  Academic Article
• Intensive Initial Oral Anticoagulation and Shorter Heparin Treatment in Deep Vein Thrombosis  Academic Article
• Interaction of histidine-rich glycoprotein with human T lymphocytes  Academic Article
• Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin  Academic Article
• Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system  Academic Article
• Interactions of polylysine with platelets  Article
• Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys  Academic Article
• Intracardiac shunt with hypoxemia caused by right ventricular dysfunction following pericardiocentesis  Academic Article
• Intraoperative Heparin Flushes and Subsequent Acute Heparin-induced Thrombocytopenia   Academic Article
• Intraoperative anticoagulation and limb amputations in patients with immune heparin‐induced thrombocytopenia who require vascular surgery  Academic Article
• Intravascular Haemolysis with Experimentally Produced Vascular Thrombi  Academic Article
• Intravascular Targeting of a New Anticoagulant Heparin Compound  Academic Article
• Intravascular coagulation in a case of Clostridium perfringens septicaemia: treatment by exchange transfusion and heparin.  Academic Article
• Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia  Academic Article
• Intravenous heparin for the prevention of stroke progression in acute partial stable stroke.  Academic Article
• Investigation of a platelet factor 4 polymorphism on the immune response in patients with heparin-induced thrombocytopenia  Academic Article
• Investigation of the Anticoagulant Mechanisms of a Covalent Antithrombin-Heparin Complex  Academic Article
• Investigations of the effectiveness of heparin variants as inhibitors of histones  Academic Article
• Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice  Academic Article
• Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis?  Academic Article
• Isoform composition of antithrombin in a covalent antithrombin–heparin complex  Academic Article
• Laboratory diagnosis of heparin‐induced thrombocytopenia  Academic Article
• Laboratory diagnosis of immune heparin-induced thrombocytopenia.  Academic Article
• Laboratory testing for VITT antibodies  Academic Article
• Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: A survey of North American specialized coagulation laboratories  Academic Article
• Laboratory testing for heparin-induced thrombocytopenia.  Academic Article
• Laboratory testing for heparin‐induced thrombocytopenia: a conceptual framework and implications for diagnosis  Academic Article
• Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?  Academic Article
• Lack of Relationship Between Enhanced Bleeding Induced by Heparin and Other Sulfated Polysaccharides and Enhanced Catalysis of Thrombin Inhibition  Academic Article
• Life-Threatening Thrombosis in Mice With Targeted Arg48-to-Cys Mutation of the Heparin-Binding Domain of Antithrombin  Academic Article
• Limitations of conventional treatment options for heparin-induced thrombocytopenia.  Academic Article
• Limitations of the particle immunofiltration assay test for diagnosis of heparin‐induced thrombocytopenia  Academic Article
• Localization of heparin and low-molecular-weight heparin in the rat kidney  Academic Article
• Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation?  Conference Paper
• Long-term Sequelae of Calf Vein Thrombosis Treated with Heparin or Low-dose Streptokinase  Academic Article
• Looking forward in the treatment of deep-vein thrombosis  Academic Article
• Low Molecular Weight Heparin  Academic Article
• Low Molecular Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results  Academic Article
• Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism  Conference Paper
• Low molecular weight heparin and unfractionated heparin in the early pharmacologic management of acute coronary syndromes: a meta-analysis of randomized clinical trials.  Academic Article
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer  Academic Article
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer  Academic Article
• Low molecular weight heparin: laboratory properties and clinical evaluation. A review.  Academic Article
• Low molecular weight heparins and heparinoids  Academic Article
• Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial  Academic Article
• Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism  Academic Article
• Low-Molecular-Weight Heparin and Deep-Vein Thrombosis  Academic Article
• Low-Molecular-Weight Heparin for Pulmonary Embolism  Academic Article
• Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism  Academic Article
• Low-Molecular-Weight Heparin versus Unfractionated Heparin for Unstable Coronary Disease  Academic Article
• Low-Molecular-Weight Heparin vs. Warfarin for Prophylaxis against Deep-Vein Thrombosis  Academic Article
• Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery  Academic Article
• Low-molecular-weight heparin for the treatment of venous thromboembolism.  Academic Article
• Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis  Academic Article
• Low-molecular-weight heparin: from the bench to the orthopedic patient.  Academic Article
• Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis  Academic Article
• Lung Deposition and Clearance of Inhaled ^99mTc-Heparin in Healthy Volunteers  Academic Article
• Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study  Academic Article
• Management Of Venous Thromboembolism: Optimization By Clinical Trials  Academic Article
• Management of Anticoagulation before and after Elective Surgery  Academic Article
• Management of Deep Vein Thrombosis and Pulmonary Embolism  Academic Article
• Management of anti-thrombin III deficiency during pregnancy without administration of anti-thrombin III  Academic Article
• Management of heparin-induced thrombocytopenia  Academic Article
• Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban  Academic Article
• Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses  Academic Article
• Management of iliofemoral thrombosis in a pregnant patient with heparin resistance  Academic Article
• Management of unstable angina and myocardial infarction  Academic Article
• Maximum 24‐hour platelet count fall: Metric for improving the diagnosis of heparin‐induced thrombocytopenia among patients with intermediate probability 4Ts scores  Academic Article
• Measurement of the Activated Partial Thromboplastin Time from a Capillary (fingerstick) Sample of Whole Blood: A New Method for Monitoring Heparin Therapy  Academic Article
• Mechanism of Action and Monitoring of Anticoagulants  Academic Article
• Mechanism of Action and Pharmacology of Unfractionated Heparin  Academic Article
• Mechanism of Catalysis of Inhibition of Factor IXa by Antithrombin in the Presence of Heparin or Pentasaccharide  Academic Article
• Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo  Academic Article
• Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex  Academic Article
• Mechanisms Responsible for Catalysis of the Inhibition of Factor Xa or Thrombin by Antithrombin Using a Covalent Antithrombin-Heparin Complex  Academic Article
• Mechanisms for Inhibition of the Generation of Thrombin Activity by Sulfated Polysaccharides  Academic Article
• Mechanisms for elevated fibrin/fibrinogen degradation products in acute experimental pulmonary embolism  Academic Article
• Mechanisms for the anticoagulant effect of heparin and related polysaccharides.  Academic Article
• Mechanisms of Action of Heparin: Applications to the Development of Derivatives of Heparin and Heparinoids with Antithrombotic Properties  Academic Article
• Mechanistic Studies of DNase I Activity: Impact of Heparin Variants and PAD4  Academic Article
• Meta-Analysis Comparing Bivalirudin Versus Heparin Monotherapy on Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention  Academic Article
• Meta-Analysis of Continuous Oral Anticoagulants Versus Heparin Bridging in Patients Undergoing CIED Surgery: Reappraisal after the BRUISE Study  Academic Article
• Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention  Academic Article
• Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients  Academic Article
• Microangiopathic Haemolytic Anaemia (MHA)  Academic Article
• Microangiopathic Haemolytic Anaemia: The Occurrence of Haemolysis in Experimentally Produced Vascular Disease  Academic Article
• Microangiopathic Haemolytic Anaemia: the Experimental Production of Haemolysis and Red-Cell Fragmentation by Defibrination in Vivo  Academic Article
• Microangiopathic Hemolytic Anemia  Academic Article
• Microheterogeneity of antithrombin III  Academic Article
• Minimizing errors of omission: Behavioural rEenforcement of Heparin to Avert Venous Emboli: The BEHAVE Study*  Academic Article
• Mixing study to diagnose heparin‐resistance caused by functional antithrombin deficiency  Academic Article
• Modification of Polyurethane Surface with an Antithrombin–Heparin Complex for Blood Contact: Influence of Molecular Weight of Polyethylene Oxide Used as a Linker/Spacer  Academic Article
• Modulation of the Enzymatic Activity of α-Thrombin by Polyanions: Consequences on Intrinsic Activation of Factor V and Factor VIII  Academic Article
• Molecular Basis for the Resistance of Fibrin-Bound Thrombin to Inactivation by Heparin/Serpin Complexes  Academic Article
• Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin  Academic Article
• Molecular cloning and expression of rabbit antithrombin III  Academic Article
• Monitoring Heparin Therapy  Academic Article
• Monitoring unfractionated heparin with the aPTT: Time for a fresh look  Academic Article
• More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACT  Academic Article
• Morphological analysis of microparticle generation in heparin-induced thrombocytopenia  Academic Article
• Multicentre evaluation of 5B9, a monoclonal anti‐PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology  Academic Article
• Multicentric Evaluation of a New PT Reagent Based on Recombinant Human Tissue Factor and Synthetic Phospholipids  Academic Article
• Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor  Academic Article
• Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia  Academic Article
• Natural, not immune; classical, not alternative  Academic Article
• Navigating the anticoagulant landscape in 2017  Academic Article
• Neutralization of Heparin Activity  Academic Article
• Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia  Academic Article
• New Anticoagulants  Academic Article
• New Antithrombotic Drugs: Beyond Aspirin and Heparin  Academic Article
• New Approaches for Deep Vein Thrombosis Occurring After Surgery  Academic Article
• New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia  Academic Article
• New anticoagulant strategies.  Academic Article
• New developments in anticoagulants: Past, present and future  Academic Article
• Newer Anticoagulants in Critically Ill Patients  Academic Article
• Newer Strategies for the Treatment of Heparin-Induced Thrombocytopenia  Academic Article
• No significant improvement in diagnostic specificity of an anti‐PF4/polyanion immunoassay with use of high heparin confirmatory procedure  Academic Article
• Non-biological factors in day to day variation of heparin requirements.  Academic Article
• Nonhemorrhagic Complications of Anticoagulant Therapy  Academic Article
• Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia  Academic Article
• Nonleg Venous Thrombosis in Critically Ill Adults  Conference Paper
• Non‐necrotizing heparin‐induced skin lesions and the 4T’s score  Academic Article
• Novel anticoagulant agents: introduction  Academic Article
• Observations in anticoagulant and thrombolytic therapy in pulmonary embolism  Academic Article
• Off-pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia  Academic Article
• On the interaction of rabbit antithrombin III with the luminal surface of the normal and deendothelialized rabbit thoracic aorta in vitro  Academic Article
• Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits  Academic Article
• Optical Densities Reduce Odds of Heparin-induced Thrombocytopenia Over-diagnosis  Academic Article
• Optimal Dosing of Subcutaneous Unfractionated Heparin for the Treatment of Deep Vein Thrombosis  Academic Article
• Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis  Academic Article
• Optimal therapeutic level of heparin therapy in patients with venous thrombosis  Academic Article
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Orgaran in the Prevention of Deep Vein Thrombosis in Stroke Patients  Academic Article
• Orthotopic liver transplantation in a patient with combined hemophilia A and B  Academic Article
• Otamixaban in acute coronary syndromes  Academic Article
• Overview of low molecular weight heparins and heparinoids: basic and clinical aspects.  Academic Article
• PATHOPHYSIOLOGY OF HEPARIN-INDUCED THROMBOCYTOPENIA  Academic Article
• PF4‐dependent immunoassays and inferential detection of HIT antibodies  Academic Article
• PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan  Academic Article
• Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation  Academic Article
• Pancreatic pseudocyst: heparin-induced haemorrhage through the ampulla of Vater.  Academic Article
• Parenteral Anticoagulants  Academic Article
• Parenteral Anticoagulants  Academic Article
• Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation  Academic Article
• Parenteral anticoagulation in ambulatory patients with cancer  Academic Article
• Parenteral anticoagulation in ambulatory patients with cancer  Academic Article
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Peptide-glycosaminoglycan cluster formation involving cell penetrating peptides  Academic Article
• Performance characteristics of a rapid assay for anti‐PF4/heparin antibodies: the particle immunofiltration assay  Academic Article
• Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL ® HIT-Ab (PF4-H) ] for the diagnosis of immune heparin-induced thrombocytopenia  Academic Article
• Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry)  Academic Article
• Perioperative Management of Antithrombotic Therapy  Academic Article
• Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide  Academic Article
• Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.  Academic Article
• Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation  Academic Article
• Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists  Academic Article
• Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants  Academic Article
• Periprocedural anticoagulation practices in warfarin-treated patients who require elective angiography with or without percutaneous coronary intervention: A retrospective chart review  Academic Article
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Academic Article
• Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis  Academic Article
• Pharmacologic tools to reduce bleeding in surgery.  Academic Article
• Pharmacological Actions of Sulodexide  Academic Article
• Pharmacology of the low-molecular-weight heparins  Academic Article
• Physician Preferences for Perioperative Anticoagulation in Patients With a Mechanical Heart Valve Who Are Undergoing Elective Noncardiac Surgery  Academic Article
• Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis  Academic Article
• Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass  Academic Article
• Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: A 6-year experience from a reference laboratory  Academic Article
• Placental transport of low molecular weight heparin in the pregnant sheep  Academic Article
• Plasma Anticoagulant Mechanisms of Heparin, Heparan Sulfate, and Dermatan Sulfate  Academic Article
• Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications  Academic Article
• Plasma betathromboglobulin and serum fragment E in acute partial stroke  Academic Article
• Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities  Academic Article
• Plasma fibrinopeptide A levels in symptomatic venous thromboembolism  Academic Article
• Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor.  Academic Article
• Platelet Activation Testing for Heparin-Induced Thrombocytopenia Antibodies  Academic Article
• Platelet Count Monitoring and Laboratory Testing for Heparin-Induced Thrombocytopenia  Academic Article
• Platelet Count Monitoring and Laboratory Testing for Heparin-Induced Thrombocytopenia  Academic Article
• Platelet Interactions with the Endothelium and the Subendothelium: the Role of Thrombin and Prostacyclin  Academic Article
• Platelet Microparticle Generation Assay for Detection of HIT Antibodies: Advance, Retreat, or Too Soon to Tell?  Academic Article
• Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review  Academic Article
• Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein.  Academic Article
• Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay  Academic Article
• Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome  Academic Article
• Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy  Academic Article
• Platelet-activating anti-PF4 disorders: An overview  Academic Article
• Platelet‐activating immune complexes identified in critically ill COVID‐19 patients suspected of heparin‐induced thrombocytopenia  Academic Article
• Polypeptide-Polysaccharide Conjugates Produced by Spontaneous Non-Enzymatic Glycation  Academic Article
• Polyphosphate binds with high affinity to exosite II of thrombin  Academic Article
• Polyurethane modified with an antithrombin-heparin complex via polyethylene oxide linker/spacers: Influence of PEO molecular weight and PEO-ATH bond on catalytic and direct anticoagulant functions  Academic Article
• Pork or beef?  Academic Article
• Postpartum management of women at increased risk of thrombosis--results of a Canadian pilot survey.  Academic Article
• Pre-operative Plasma Levels of Thrombin-Antithrombin III Complexes Correlate with the Development of Venous Thrombosis after Major Hip or Knee Surgery  Academic Article
• Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis  Academic Article
• Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition  Academic Article
• Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: A report from the Total Occlusion Study of Canada (TOSCA)  Academic Article
• Pregnancy, Heparin and Osteoporosis  Academic Article
• Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery  Academic Article
• Preparation and partial characterization of human plasma depleted of antithrombin-III by heparin-sepharose affinity chromatography  Academic Article
• Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE  Academic Article
• Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study  Academic Article
• Preventing Venous Thromboembolism in Critically Ill Patients  Academic Article
• Prevention and treatment of venous thromboembolism in the elderly patient.  Academic Article
• Prevention of Deep Vein Thrombosis after Elective Hip Surgery  Academic Article
• Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator  Academic Article
• Prevention of Recurrent Venous Thrombosis: Warfarin versus Heparin  Academic Article
• Prevention of Thrombus Growth by Antithrombin III-Dependent and Two Direct Thrombin Inhibitors in Rabbits: Implications for Antithrombotic Therapy  Academic Article
• Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Prevention of Venous Thromboembolism  Academic Article
• Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin  Academic Article
• Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449]  Academic Article
• Prevention of deep venous thrombosis.  Academic Article
• Prevention of left ventricular mural thrombus  Academic Article
• Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: Importance of heparin cofactor II  Academic Article
• Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study  Academic Article
• Prevention of venous thrombosis with small, subcutaneous doses of heparin  Academic Article
• Principles and practice of coronary thrombolysis and conjunctive treatment  Academic Article
• Proceedings: Efficacy and monitoring of heparin therapy in experimental venous thrombosis.  Academic Article
• Proceedings: Heparin kinetics in venous thrombosis and pulmonary embolism.  Academic Article
• Proceedings: The role of heparin on the inhibition of platelet adhesion to damaged arterial endothelial surface  Article
• Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism  Academic Article
• Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation  Academic Article
• Prognostic importance of preoperative anti-PF4/heparin antibodies in patients undergoing cardiac surgery  Academic Article
• Progressive thrombocytopenia after cardiac surgery in a 67-year-old man  Academic Article
• Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite “Therapeutic” Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding  Academic Article
• Prolonged Prothrombin Time and Partial Thromboplastin Time in Disseminated Intravascular Coagulation not Due to Deficiency of Factors V and VIII  Academic Article
• Prophylactic doses of enoxaparin and heparin inhibit prothrombin activation.  Academic Article
• Prophylactically Effective Doses of Enoxaparin and Heparin Inhibit Prothrombin Activation  Academic Article
• Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent  Academic Article
• Prophylaxis and Therapy of Venous Thromboembolism  Academic Article
• Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study  Academic Article
• Prophylaxis of Venous Thromboembolism in Stroke Patients  Academic Article
• Prophylaxis of venous thromboembolism. An overview.  Academic Article
• Pros and cons of catheter lock solutions  Academic Article
• Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia  Academic Article
• Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients  Academic Article
• Protamine (heparin)‐induced thrombocytopenia: a review of the serological and clinical features associated with anti‐protamine/heparin antibodies  Academic Article
• Protamine Requirements in Cardiac Surgery: Effect of Changes in the Heparin Reference Standard  Academic Article
• Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex  Academic Article
• Prothrombotic genetic risk factors and heparin-induced thrombocytopenia  Academic Article
• Pulmonary Embolism in the Elderly  Academic Article
• Pulmonary hypertension and pregnancy: a series of eight cases  Academic Article
• Putting heparin into perspective: its history and the evolution of its use during percutaneous coronary interventions.  Academic Article
• Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassays  Academic Article
• Questioning the Treatment of Venous Thromboembolism  Academic Article
• RESOLUTION OF ACUTE MASSIVE PULMONARY EMBOLISM AFTER PULMONARY ARTERIAL INFUSION OF STREPTOKINASE  Academic Article
• Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)  Academic Article
• Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.  Academic Article
• Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study  Academic Article
• Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.  Academic Article
• Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention  Academic Article
• Randomized, Controlled Trial of Individualized Heparin and Protamine Management in Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass  Academic Article
• Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments]  Academic Article
• Rationale Behind the Development of Low Molecular Weight Heparin Derivatives  Academic Article
• Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis  Academic Article
• Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial  Academic Article
• Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.  Academic Article
• Reading between the (Guidelines). Management of submassive pulmonary embolism in the first trimester of pregnancy  Academic Article
• Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update  Academic Article
• Recurrent Venous Thrombosis and Heparin Therapy  Academic Article
• Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial  Academic Article
• Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin  Academic Article
• Relationship Between Dose, Anticoagulant Effect and the Clinical Efficacy and Safety of Heparin  Conference Paper
• Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes  Academic Article
• Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis  Academic Article
• Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin  Academic Article
• Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin  Academic Article
• Renal venous thrombosis in a newborn with prothrombotic risk factors  Academic Article
• Requirement of Lysine Residues Outside of the Proposed Pentasaccharide Binding Region for High Affinity Heparin Binding and Activation of Human Antithrombin III  Academic Article
• Resolution of Experimental Pulmonary Emboli with Heparin and Streptokinase in Different Dosage Regimens  Academic Article
• Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides  Academic Article
• Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s  Academic Article
• Reversing Anticoagulant Therapy  Academic Article
• Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis  Academic Article
• Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism  Academic Article
• Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis  Academic Article
• Risks to the Fetus of Anticoagulant Therapy During Pregnancy  Academic Article
• Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography  Academic Article
• Rivaroxaban for treatment of HIT: A riveting first experience  Academic Article
• Rivaroxaban for treatment of suspected or confirmed heparin‐induced thrombocytopenia study  Academic Article
• Rivaroxaban in treatment refractory heparin-induced thrombocytopenia  Academic Article
• Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model.  Academic Article
• Safe bridging to warfarin in heparin-induced thrombocytopenia  Academic Article
• Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study  Academic Article
• Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism  Academic Article
• Sample matrix and high-sensitivity cardiac troponin I assays  Academic Article
• Scoring systems for heparin-induced thrombocytopenia (HIT): Whither now?  Academic Article
• Selective cleavage of heparin using aqueous 2-hydroxypyridine: Production of an aldose-terminating fragment with high anticoagulant activity  Academic Article
• Senescent human neutrophil binding to thrombospondin (TSP): evidence for a TSP‐independent pathway of phagocytosis by macrophages  Academic Article
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia  Academic Article
• Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin  Academic Article
• Serotonin‐release assay‐negative heparin‐induced thrombocytopenia  Academic Article
• Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative: HIT or not HIT ?  Academic Article
• Serum-induced platelet procoagulant activity: An assay for the characterization of prothrombotic disorders  Academic Article
• Setting a standard for venous thromboembolism prophylaxis  Academic Article
• Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial  Academic Article
• Should vitamin K be administered when HIT is diagnosed after administration of coumarin?  Academic Article
• Site-directed mutagenesis of alanine-382 of human antithrombin III  Academic Article
• Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis  Academic Article
• So, Does Low-Molecular-Weight Heparin Cause Less Heparin-Induced Thrombocytopenia Than Unfractionated Heparin or Not?  Academic Article
• Soluble Ligands of the αvβ4 Integrin Mediate Enhanced Tyrosine Phosphorylation of Multiple Proteins in Adherent Bovine Pulmonary Artery Endothelial Cells  Academic Article
• Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia  Academic Article
• Spontaneous heparin-induced thrombocytopenia syndrome presenting as bilateral adrenal infarction after knee arthroplasty  Academic Article
• Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder  Academic Article
• Standard and Low Molecular Weight Heparin Have no Effect on Tissue Plasminogen Activator Induced Plasma Clot Lysis or Fibrinogenolysis  Academic Article
• Standard assays underestimate the concentration of heparin in neonatal plasma.  Academic Article
• Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial  Academic Article
• Streptokinase Therapy in Acute Major Pulmonary Embolism: Effectiveness and Problems  Academic Article
• Streptokinase in acute major pulmonary embolism.  Academic Article
• Streptokinase in the Treatment of Major Pulmonary Embolism-Experience with Twenty-five Patients  Academic Article
• Structural Effects of a Covalent Linkage Between Antithrombin and Heparin: Covalent N-Terminus Attachment of Heparin Enhances the Maintenance of Antithrombin's Activated State  Academic Article
• Studies of the anti–platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens  Academic Article
• Studies of the immune response in heparin-induced thrombocytopenia  Academic Article
• Studies on the frequency of heparin-associated thrombocytopenia  Academic Article
• Studies on the medical treatment of deep vein thrombosis.  Academic Article
• Subcutaneous Heparin for Venous Thrombosis  Academic Article
• Subcutaneous compared with intravenous heparin for deep vein thrombosis.  Academic Article
• Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin  Academic Article
• Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial  Academic Article
• Successors to heparin: new antithrombotic agents.  Academic Article
• Superior mesenteric vein thrombosis after the Whipple procedure: an aggressive, combined treatment approach.  Academic Article
• Surface modification of polydimethylsiloxane with a covalent antithrombin–heparin complex to prevent thrombosis  Academic Article
• Surface modification with an antithrombin–heparin complex for anticoagulation: Studies on a model surface with gold as substrate  Academic Article
• Surgical exposure of the carotid artery for endovascular interventional procedures  Academic Article
• Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin  Academic Article
• Systematic lower limb phlebography in acute spinal cord injury in 147 patients  Academic Article
• TREATMENT OF PULMONARY EMBOLISM  Academic Article
• Temporal Aspects of Heparin-Induced Thrombocytopenia  Academic Article
• Testing for Heparin-Induced Thrombocytopenia Antibodies  Academic Article
• Testing for heparin‐induced thrombocytopenia: are we there yet?  Academic Article
• The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients  Academic Article
• The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, α-thrombin  Academic Article
• The APTT Response of Pregnant Plasma to Unfractionated Heparin  Academic Article
• The Activated Partial Thromboplastin Time in the Control of Heparin Treatment  Academic Article
• The Antithrombotic Properties of Human Prothrombin Fragment 1.2 in Mice  Academic Article
• The Approach to Heparin-Induced Thrombocytopenia  Academic Article
• The Asp272–Glu282 Region of Platelet Glycoprotein Ibα Interacts with the Heparin-binding Site of α-Thrombin and Protects the Enzyme from the Heparin-catalyzed Inhibition by Antithrombin III  Academic Article
• The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells  Academic Article
• The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism  Academic Article
• The Duration of Oral Anticoagulation after Deep Vein Thrombosis  Academic Article
• The Effect of Antithrombin III-Independent Thrombin Inhibitors and Heparin on Fibrin Accretion onto Fibrin-Coated Polyethylene \textbar Request PDF  Academic Article
• The Effect of Heparin Adsorbed on Sepharose-Lysine on the Inactivation of Thrombin by Anti-Thrombin III  Academic Article
• The Effect of Thrombin Inhibitors on Tissue Plasminogen Activator Induced Thrombolysis in a Rat Model  Academic Article
• The Effect of Thrombin on Platelet Accumulation on the Vessel Wall - Influence of Heparin and Aspirin  Academic Article
• The Effects of Long-term Heparin Therapy During Pregnancy on Bone Density  Academic Article
• The Effects of Standard and Low Molecular Weight Heparin on Bone Nodule Formation In Vitro  Academic Article
• The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction  Academic Article
• The Efficacy and Safety of Heparin in Patients With Sepsis  Academic Article
• The Emerging Role of Immunoregulation of Fibrinogen-Related Procoagulant Fgl2 in the Success or Spontaneous Abortion of Early Pregnancy in Mice and Humans  Academic Article
• The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia  Academic Article
• The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion  Academic Article
• The Molecular Pathology of Inherited Human Antithrombin III Deficiency  Academic Article
• The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia  Academic Article
• The Pathophysiology of Heparin-Induced Thrombocytopenia  Academic Article
• The Role for Optical Density in Heparin-Induced Thrombocytopenia  Academic Article
• The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients  Academic Article
• The activated clotting time in cardiac surgery: should Celite or kaolin be used?  Academic Article
• The anti-inflammatory effects of heparin and related compounds  Academic Article
• The assay and partial characterization of macromolecular heparin depolymerase activity in rat small intestine  Academic Article
• The challenges and lessons learned in conducting clinical trials in pregnant women with antiphospholipid syndrome  Academic Article
• The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia  Academic Article
• The clinical management of heparin-induced thrombocytopenia.  Academic Article
• The diagnosis and prevention of post operative venous thrombosis.  Academic Article
• The direct thrombin inhibitor hirudin  Academic Article
• The disappearance of a low molecular weight heparin fraction (cy 216) differs from standard heparin in rabbits  Academic Article
• The effect of heparin on the affinity chromatography of plasminogen Demonstration of heparin-plasminogen interaction  Academic Article
• The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass  Academic Article
• The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria  Academic Article
• The endocarditis that was not: an unusual case of heparin-induced thrombocytopenia with unusual complications.  Academic Article
• The epitope specificity of heparin‐induced thrombocytopenia  Academic Article
• The evolving role of direct thrombin inhibitors in acute coronary syndromes.  Academic Article
• The haemorrhagic and antithrombotic effects of dermatan sulphate.  Academic Article
• The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate  Academic Article
• The inactivation of thrombin and plasmin by antithrombin III in the presence of Sepharose-heparin  Academic Article
• The influence of drugs upon the anticoagulant activity of heparin.  Academic Article
• The influence of heparin, NaCl and CaCl2 on the rate of the thrombin-antithrombin III reaction  Academic Article
• The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin-III  Academic Article
• The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin  Academic Article
• The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians  Academic Article
• The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation  Academic Article
• The paradox of heparin‐induced thrombocytopenia  Academic Article
• The pharmacokinetics and bioavailability of subcutaneously administered dihydroergotamine, heparin and the dihydroergotamine-heparin combination  Academic Article
• The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines  Academic Article
• The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin  Academic Article
• The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits  Academic Article
• The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin  Academic Article
• The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia  Academic Article
• The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia  Academic Article
• The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial  Academic Article
• The safety of percutaneous tracheostomy in patients with coagulopathy or thrombocytopenia.  Academic Article
• The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by “true” heparin-induced thrombocytopenia  Academic Article
• The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome  Academic Article
• The success of salvage procedures for failing digital replants: A retrospective cohort study  Academic Article
• The temporal profile of the anti-PF4/heparin immune response  Academic Article
• The transfusion-related acute lung injury controversy: lessons from heparin-induced thrombocytopenia  Academic Article
• The unique immunological features of heparin-induced thrombocytopenia  Academic Article
• The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. A randomized crossover study  Academic Article
• The use of well‐characterized sera for the assessment of new diagnostic enzyme‐immunoassays for the diagnosis of heparin‐induced thrombocytopenia  Academic Article
• The uses of heparin to treat burn injury.  Academic Article
• The value of monitoring heparin therapy in the prevention of recurrence in patients with venous thromboembolic disease.  Academic Article
• The variable anticoagulant response to unfractionated heparin in vivo reflects binding to plasma proteins rather than clearance  Academic Article
• Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19  Academic Article
• Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19  Academic Article
• Think of HIT  Academic Article
• Think of HIT When Thrombosis Follows Heparin  Academic Article
• Thrombin Binds to Soluble Fibrin Degradation Products Where it Is Protected From Inhibition by Heparin-Antithrombin but Susceptible to Inactivation by Antithrombin-Independent Inhibitors  Academic Article
• Thrombin Generation during Cardiac Surgery: Is Heparin the Ideal Anticoagulant?  Academic Article
• Thrombin Regulation in Children Differs from Adults in the Absence and Presence of Heparin  Academic Article
• Thrombin and Antithrombotics  Academic Article
• Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes  Academic Article
• Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival  Article
• Thrombocytopenia found uncommonly during heparin therapy  Academic Article
• Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis  Academic Article
• Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE])  Academic Article
• Thrombocytopénie induite par l’héparine  Academic Article
• Thromboembolism in Infants and Children With Gastrointestinal Failure Receiving Long-Term Parenteral Nutrition  Academic Article
• Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism  Academic Article
• Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction  Conference Paper
• Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis  Academic Article
• Thrombolysis with a Combination of Small Doses of Streptokinase and Full Doses of Heparin  Academic Article
• Thrombolytic Therapy and Fatal Pulmonary Emboli  Academic Article
• Thrombolytic Therapy for Submassive Pulmonary Embolism?  Academic Article
• Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?  Academic Article
• Thrombolytic therapy for the treatment of acute pulmonary embolism.  Academic Article
• Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis  Academic Article
• Thromboprophylaxis for hospitalized medical patients: A Multicenter Qualitative study  Academic Article
• Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin  Academic Article
• Thromboprophylaxis in medical-surgical intensive care unit patients  Academic Article
• Thromboprophylaxis in medical–surgical critically ill patients  Academic Article
• Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial  Academic Article
• Thrombosis and anticoagulation.  Academic Article
• Thrombosis and cancer: implications beyond Trousseau  Academic Article
• Thrombosis in Children  Academic Article
• Thrombotic Complications after Substitution with a FVII Concentrate  Academic Article
• Thrombotic End Point for Assessing Argatroban Therapy for Heparin-Induced Thrombocytopenia  Academic Article
• Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumption.  Academic Article
• Timeline of heparin‐induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay  Academic Article
• Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.  Academic Article
• Transient Global Amnesia as the Presenting Feature of Heparin-Induced Thrombocytopenia  Academic Article
• Transient global amnesia associated with acute heparin-induced thrombocytopenia  Academic Article
• Transient pseudothrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism  Academic Article
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Academic Article
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Academic Article
• Treatment and prophylaxis of venous thromboembolism during pregnancy  Academic Article
• Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis  Academic Article
• Treatment of Deep-Vein Thrombosis  Academic Article
• Treatment of First Episode of Venous Thrombosis  Academic Article
• Treatment of Heparin-Induced Thrombocytopenia  Academic Article
• Treatment of Patients with Microangiopathic Haemolytic Anaemia with Heparin  Academic Article
• Treatment of Venous Thromboembolism  Academic Article
• Treatment of Venous Thromboembolism in Patients with Congenital Deficiency of Antithrombin III  Academic Article
• Treatment of bleeding complications in patients on anticoagulant therapy  Academic Article
• Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective  Academic Article
• Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)  Academic Article
• Treatment of venous thromboembolic disease.  Academic Article
• Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters  Academic Article
• Tritiation of commercial heparins by reaction with NaB3H4: Chemical analysis and biological properties of the product  Academic Article
• Uncontrolled PGI2 production by whole vessel wall segments due to thrombin generation and its prevention by heparin  Academic Article
• Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction  Academic Article
• Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis  Academic Article
• Unfractionated heparin and placental pathology in high-risk pregnancies: Secondary analysis of a pilot randomized controlled trial  Academic Article
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels  Academic Article
• Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa  Academic Article
• Unfractionated versus Low-Molecular-Weight Heparin for Deep Venous Thrombosis  Academic Article
• Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder  Academic Article
• Update on heparin: what do we need to know?  Academic Article
• Updates in thrombosis in pediatrics: where are we after 20 years?  Academic Article
• Use of Antithrombotic Agents During Pregnancy  Academic Article
• Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes  Academic Article
• Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions  Academic Article
• Use of a Fixed Activated Partial Thromboplastin Time Ratio to Establish a Therapeutic Range for Unfractionated Heparin  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.  Academic Article
• Use of heparin in the investigation of obscure gastrointestinal bleeding.  Academic Article
• Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol  Academic Article
• Utility of Unfractionated Heparin in Transradial Cardiac Catheterization: A Systematic Review and Meta-analysis  Academic Article
• Utility of aPTT in monitoring unfractionated heparin in children  Academic Article
• VENOUS THROMBOEMBOLISM ASSOCIATED WITH GYNECOLOGIC SURGERY  Academic Article
• VTE Prophylaxis in Critically Ill Adults  Academic Article
• VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Academic Article
• Vasoflux, a New Anticoagulant With a Novel Mechanism of Action  Academic Article
• Vasospasm-induced Stroke in a Varsity Athlete Secondary to Ephedrine Ingestion  Academic Article
• Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia  Academic Article
• Venous thromboembolism in critical illness in a community intensive care unit  Academic Article
• Venous thromboembolism in heparin-induced thrombocytopenia  Academic Article
• Venous thromboembolism management: where do novel anticoagulants fit?  Academic Article
• Venous thromboembolism: diagnosis and management of pulmonary embolism  Academic Article
• Venous thrombosis in inflammatory bowel disease  Academic Article
• Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?  Academic Article
• Voting with your fondaparinux  Academic Article
• Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis  Academic Article
• Warfarin-Induced Skin Necrosis in 2 Patients with Protein S Deficiency: Successful Reinstatement of Warfarin Therapy  Academic Article
• Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis  Academic Article
• Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome  Academic Article
• Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more  Academic Article
• What is the potential for overdiagnosis of heparin-induced thrombocytopenia?  Academic Article
• When and how to use heparin prophylaxis and treatment.  Academic Article
• When is HIT Really HIT?  Academic Article
• Which antithrombotic to use during PCI?  Academic Article
• Who Is (Still) Getting HIT?  Academic Article
• Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass  Academic Article
• Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review  Academic Article
• Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial  Academic Article
• Zinc: An important cofactor in haemostasis and thrombosis  Academic Article
• Zn2+ Mediates High Affinity Binding of Heparin to the αC Domain of Fibrinogen  Academic Article
• [10] Archaeal histones and nucleosomes  Book
• [Anticoagulants and other drugs effective against thrombosis].  Academic Article
• [Canadian Consensus Conference on Coronary Thrombolysis--current aspects].  Academic Article
• [Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study].  Academic Article
• [Prevention of deep vein thrombosis and pulmonary thromboembolism].  Academic Article
• [Prevention of venous thrombosis in paraplegic patients. An open study of fraxiparin].  Academic Article
• [Treatment of venous thrombo--emboli].  Academic Article
• [Venous thromboemboli].  Academic Article